推荐产品
生物源
mouse
品質等級
抗體表格
purified immunoglobulin
無性繁殖
monoclonal
製造商/商標名
Chemicon®
濃度
2.2 mg/mL
技術
ELISA: suitable
運輸包裝
dry ice
目標翻譯後修改
unmodified
一般說明
Purity: 95% or greater
應用
Mouse IgG2a Monoclonal Antibody control validated for use in ELISA.
Research Category
Inflammation & Immunology
Inflammation & Immunology
Research Sub Category
Immunoglobulins & Immunology
Immunoglobulins & Immunology
外觀
Format: Purified
Purified immunoglobulin. Liquid containing no preservatives.
儲存和穩定性
Maintain at -20°C in undiluted aliquots for up to 12 months. Do not thaw and refreeze.
法律資訊
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
免責聲明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
儲存類別代碼
12 - Non Combustible Liquids
水污染物質分類(WGK)
WGK 2
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus.
Journal of virology null
Molecular immunology, 39(13), 783-789 (2003-03-06)
Methods for cell type specific targeted intracellular delivery of proteins in vivo remain limited. A murine monoclonal anti-dsDNA antibody, mAb 3E10, was selectively transported into skeletal muscle cells in vivo. The antibody bound a 200 kDa protein only found in
A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus.
Journal of immunology (Baltimore, Md. : 1950) (1950)
The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer.
BMC Cancer null
Molecular therapy. Methods & clinical development, 30, 576-592 (2023-09-11)
De novo immune responses are considered major challenges in gene therapy. With the aim to lower innate immune responses directly in cells targeted by adeno-associated virus (AAV) vectors, we equipped the vector capsid with a peptide known to interfere with
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门